Holen Sie sich die Stockscreener-App
22.22
1.37%
0.30
Vorhandelsmarkt:
22.22
Schlusskurs vom Vortag:
$21.92
Offen:
$22
24-Stunden-Volumen:
162.40K
Relative Volume:
0.80
Marktkapitalisierung:
$414.90M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+3.64%
1M Leistung:
+12.17%
6M Leistung:
-47.10%
1J Leistung:
+33.53%
1-Tages-Spanne:
$21.64
$22.99
1-Wochen-Bereich:
$21.23
$23.77
52-Wochen-Spanne:
$13.70
$61.07
Tectonic Therapeutic Inc Stock (TECX) Company Profile
Firmenname
Tectonic Therapeutic Inc
Sektor
Branche
Telefon
(339) 666-3320
Adresse
490 ARSENAL WAY, WATERTOWN
Vergleichen Sie TECX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TECX
Tectonic Therapeutic Inc
|
22.22 | 400.34M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Tectonic Therapeutic Inc Stock (TECX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-21 | Eingeleitet | Truist | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-21 | Eingeleitet | Mizuho | Outperform |
| 2024-11-20 | Eingeleitet | Raymond James | Outperform |
| 2024-08-22 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-26 | Eingeleitet | Piper Sandler | Overweight |
| 2024-06-24 | Eingeleitet | TD Cowen | Buy |
| 2023-12-18 | Herabstufung | Mizuho | Buy → Neutral |
| 2022-01-05 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-11-19 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2021-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-05-27 | Eingeleitet | Needham | Buy |
| 2021-03-09 | Eingeleitet | Barclays | Overweight |
| 2021-03-02 | Eingeleitet | Stifel | Hold |
| 2020-11-11 | Eingeleitet | Berenberg | Buy |
| 2020-03-31 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2019-06-27 | Eingeleitet | Mizuho | Buy |
| 2019-04-05 | Eingeleitet | Janney | Buy |
| 2018-10-10 | Eingeleitet | Guggenheim | Buy |
| 2018-10-02 | Bestätigt | H.C. Wainwright | Buy |
| 2018-09-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-07-16 | Eingeleitet | Wedbush | Outperform |
| 2018-07-16 | Eingeleitet | Wells Fargo | Outperform |
Alle ansehen
Tectonic Therapeutic Inc Aktie (TECX) Neueste Nachrichten
What drives Tectonic Therapeutic Inc. stock priceExponential wealth increase - jammulinksnews.com
Is Tectonic Therapeutic Inc. a good long term investmentUnmatched profit potential - jammulinksnews.com
What analysts say about Tectonic Therapeutic Inc. stockMarket-crushing stock picks - jammulinksnews.com
Tectonic Therapeutic (NASDAQ:TECX) Now Covered by Truist Financial - Defense World
Tectonic Therapeutic, Inc. Rings the Closing Bell - Nasdaq
Truist Securities initiates Tectonic Therapeutics stock with Buy rating - Investing.com India
Tectonic Therapeutic Inc. Stock Analysis and ForecastStrong return on assets - printweek.in
What institutions are buying Tectonic Therapeutic Inc. stock nowFree Stock Market Analysis Courses - Newser
What analysts say about Tectonic Therapeutic Inc. stock outlookBreakout Level Watch - Newser
What makes Tectonic Therapeutic Inc. stock price move sharplyLow Risk Consistent Winners - Newser
How Tectonic Therapeutic Inc. stock performs during market volatilityLong Term Secure Gain Stocks - Newser
Why Tectonic Therapeutic Inc. stock attracts strong analyst attentionFree Deep Market Trend Analysis - Newser
Russell 2000 Implied Analyst Target Price at $269.34, 20.67% Upside to Current Price of $223.21. - AInvest
Tectonic Therapeutic shares fall 1.44% intraday after filing $400 million mixed shelf. - AInvest
Tectonic Therapeutics: Strategic Capital Allocation Fuels Growth in Untapped GPCR Markets - AInvest
Tectonic Therapeutic Files $400 Million Mixed Shelf - MarketScreener
Clinical-Stage Biotech Tectonic Therapeutic Secures Coveted Russell 3000 Index Position - Stock Titan
Raymond James Resumes Coverage of Tectonic Therapeutic (TECX) With an Outperform Rating - MSN
13 Small Cap Stocks Analysts Are Bullish On - Insider Monkey
Tectonic Therapeutic (NASDAQ:TECX) & Invivyd (NASDAQ:IVVD) Head-To-Head Comparison - Defense World
We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth - Yahoo Finance
Tectonic Therapeutic (NASDAQ:TECX) Coverage Initiated at Raymond James - Defense World
Analysts Set Tectonic Therapeutic (NASDAQ:TECX) PT at $80.50 - Defense World
Tectonic Therapeutic (NASDAQ:TECX) Upgraded at Lifesci Capital - Defense World
Lifesci Capital Initiates Coverage on Tectonic Therapeutic (NASDAQ:TECX) - Defense World
tectonic therapeutic holds annual meeting, elects directors By Investing.com - Investing.com India
LifeSci Capital Initiates Coverage of Tectonic Therapeutic (TECX) with Outperform Recommendation - Nasdaq
Finanzdaten der Tectonic Therapeutic Inc-Aktie (TECX)
Es liegen keine Finanzdaten für Tectonic Therapeutic Inc (TECX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):